Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to give written consent to take part, or a legal guardian can do this on your behalf.
- You are 18 years old or older.
- You have been diagnosed with Alzheimer's disease, mild cognitive impairment (early memory/thinking difficulties), pre-mild cognitive impairment (very early signs or risk factors for memory problems), or have normal thinking and memory function — all assessed using recognised medical guidelines (confirm with trial site).
- You are willing to be followed up and have information collected over a period of 5 years.
Who may not be able to join:
- You are under 18 years old.
- You have a medical or mental health condition that would make it difficult to attend the initial and follow-up visits.
- There is no one available who knows you well enough to provide information about you to the study team.
- You have a current or past neurological or psychiatric condition such as schizophrenia, epilepsy, brain tumours, severe head injury, or other conditions that can cause memory or thinking problems.
- You are unwilling to complete thinking and memory tests or provide biological samples (such as blood).
- You have a history of alcohol or drug misuse.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianping Jia, Doctor, Xuanwu Hospital of Capital Medical University
Phone: #8610-83199449
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
A multiple diagnostic kit for early diagnosis of AD.; A 5-years risk prediction model for onset and progression of AD among elderly population in China.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.